Literature DB >> 24384565

Methylprednisolone-induced hepatotoxicity: experiences from global adverse drug reaction surveillance.

Ola Caster1, Anita Conforti, Ermelinda Viola, I Ralph Edwards.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24384565     DOI： 10.1007/s00228-013-1632-3

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  8 in total

1.  Effects of pulse methylprednisolone on inflammatory mediators in peripheral blood, synovial fluid, and synovial membrane in rheumatoid arthritis.

Authors:  P P Youssef; D R Haynes; S Triantafillou; A Parker; J R Gamble; P J Roberts-Thomson; M J Ahern; M D Smith
Journal:  Arthritis Rheum       Date:  1997-08

2.  EFNS guideline on treatment of multiple sclerosis relapses: report of an EFNS task force on treatment of multiple sclerosis relapses.

Authors:  F Sellebjerg; D Barnes; G Filippini; R Midgard; X Montalban; P Rieckmann; K Selmaj; L H Visser; P S Sørensen
Journal:  Eur J Neurol       Date:  2005-12       Impact factor: 6.089

Review 3.  Corticosteroid-induced adverse events in adults: frequency, screening and prevention.

Authors:  Laurence Fardet; Abdulrhaman Kassar; Jean Cabane; Antoine Flahault
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

4.  Comparison of the effectiveness and tolerability of intravenous or oral glucocorticoids associated with orbital radiotherapy in the management of severe Graves' ophthalmopathy: results of a prospective, single-blind, randomized study.

Authors:  C Marcocci; L Bartalena; M L Tanda; L Manetti; E Dell'Unto; R Rocchi; G Barbesino; B Mazzi; M P Bartolomei; P Lepri; F Cartei; M Nardi; A Pinchera
Journal:  J Clin Endocrinol Metab       Date:  2001-08       Impact factor: 5.958

5.  A meta-analysis of methylprednisolone in recovery from multiple sclerosis exacerbations.

Authors:  D M Miller; B Weinstock-Guttman; F Béthoux; J C Lee; G Beck; V Block; L Durelli; L LaMantia; D Barnes; F Sellebjerg; R A Rudick
Journal:  Mult Scler       Date:  2000-08       Impact factor: 6.312

6.  Multiple sclerosis.

Authors:  Alastair Compston; Alasdair Coles
Journal:  Lancet       Date:  2008-10-25       Impact factor: 79.321

Review 7.  [Recurrent acute liver toxicity from intravenous methylprednisolone].

Authors:  M Rivero Fernández; J M Riesco; V F Moreira; A Moreno; A López San Román; G Arranz; L Ruiz Del Arbol
Journal:  Rev Esp Enferm Dig       Date:  2008-11       Impact factor: 2.086

8.  Liver injury induced by high-dose methylprednisolone therapy: a case report and brief review of the literature.

Authors:  Krzysztof Gutkowski; Alina Chwist; Marek Hartleb
Journal:  Hepat Mon       Date:  2011-08       Impact factor: 0.660
  8 in total
  9 in total

1.  Comedications alter drug-induced liver injury reporting frequency: Data mining in the WHO VigiBase™.

Authors:  Ayako Suzuki; Nancy A Yuen; Katarina Ilic; Richard T Miller; Melinda J Reese; H Roger Brown; Jeffrey I Ambroso; J Gregory Falls; Christine M Hunt
Journal:  Regul Toxicol Pharmacol       Date:  2015-05-16       Impact factor: 3.271

Review 2.  Recent Advances in the Histopathology of Drug-Induced Liver Injury.

Authors:  David E Kleiner
Journal:  Surg Pathol Clin       Date:  2018-06

3.  Automatic Identification of Messages Related to Adverse Drug Reactions from Online User Reviews using Feature-based Classification.

Authors:  Jingfang Liu; Pengzhu Zhang; Yingjie Lu
Journal:  Iran J Public Health       Date:  2014-11       Impact factor: 1.429

4.  Quantitative benefit-risk assessment of methylprednisolone in multiple sclerosis relapses.

Authors:  Ola Caster; I Ralph Edwards
Journal:  BMC Neurol       Date:  2015-10-16       Impact factor: 2.474

5.  Reactivation of Hepatitis C Virus and Its Clinical Outcomes in Patients Treated with Systemic Chemotherapy or Immunosuppressive Therapy.

Authors:  Hae Lim Lee; Si Hyun Bae; Bohyun Jang; Seawon Hwang; Hyun Yang; Hee Chul Nam; Pil Soo Sung; Sung Won Lee; Jeong Won Jang; Jong Young Choi; Nam Ik Han; Byung Joo Song; Jong Wook Lee; Seung Kew Yoon
Journal:  Gut Liver       Date:  2017-11-15       Impact factor: 4.519

6.  Hepatotoxicity after high-dose intravenous methylprednisolone in multiple sclerosis patients.

Authors:  Milagros Hidalgo de la Cruz; Jahir Andrés Miranda Acuña; Alberto Lozano Ros; María Vega Catalina; Emilio Salinero Paniagua; Gerardo Clemente Ricote; Clara Dionisia De Andrés Frutos; María Luisa Martínez Ginés
Journal:  Clin Case Rep       Date:  2017-06-09

7.  Methimazole-induced liver injury overshadowed by methylprednisolone pulse therapy: Case report.

Authors:  Silvijus Abramavicius; Dzilda Velickiene; Edmundas Kadusevicius
Journal:  Medicine (Baltimore)       Date:  2017-09       Impact factor: 1.889

Review 8.  Drug-Induced Liver Injury: Highlights from a Review of the 2015 Literature.

Authors:  Philip Sarges; Joshua M Steinberg; James H Lewis
Journal:  Drug Saf       Date:  2016-09       Impact factor: 5.228

9.  Liver injury after pulsed methylprednisolone therapy in multiple sclerosis patients.

Authors:  Viviana Nociti; Marco Biolato; Chiara De Fino; Assunta Bianco; Francesco Antonio Losavio; Matteo Lucchini; Giuseppe Marrone; Antonio Grieco; Massimiliano Mirabella
Journal:  Brain Behav       Date:  2018-05-04       Impact factor: 2.708
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.